Genomic strategies to untangle the etiology of autism: A primer.

This article explains how scientists use genetic testing to understand what causes autism. Autism affects about 2 in every 100 people and can look very different from person to person. The researchers explain that autism has many different genetic causes - some genetic changes happen naturally, others are passed down from parents. Some genetic changes are rare, while others are more common. This overview helps explain the different ways scientists study autism genetics.

This 2023 commentary provides an overview of genomic strategies used to understand the genetic causes of autism spectrum disorder (ASD). The authors explain that ASD affects approximately 2.3% of the population and is highly heterogeneous both in presentation and genetic underpinnings. The review discusses how advancing genomic technologies are revealing the genetic architecture of ASD, including both spontaneous and inherited genetic alterations that can be rare or common in the population. The commentary aims to summarize major genomic research approaches and key genetic findings associated with ASD, helping to clarify the complex genetic landscape underlying autism.

This overview can help clinicians understand the genetic complexity of autism and the various genomic approaches available for research and potential clinical applications. Understanding the heterogeneous genetic architecture may inform discussions about genetic testing options and support individualized treatment approaches for autistic individuals.

This is a commentary/primer rather than original research, so it does not present new empirical findings. The abstract does not specify which genomic strategies or major findings are discussed, limiting detailed assessment of the evidence presented.

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by deficits in communication, diminished social skills, and restrictive and repetitive behaviors and interests. ASD affects approximately 2.3% of the population and is highly heterogeneous, both phenotypically and genetically. As genomic technologies advance, our understanding of the genetic architecture of ASD is becoming clearer, encompassing spontaneous and inherited alterations throughout the genome, and delineating alterations that are either rare or common in the population. This commentary provides an overview of the genomic strategies and resulting major findings of genetic alterations associated with ASD.